跳至主要内容
临床试验/IRCT20181117041682N2
IRCT20181117041682N2招募中2 期

Evaluation the Effect of Adding Galantamine to Second Generation Antipsychotics, on Negative Symptoms of Schizophrenia

Ahvaz University of Medical Sciences0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Diagnosis of schizophrenia based on the DSM-5
  • Age of 18-55 years
  • Get at least one second-generation anti-psychotic drug within the dose range
  • Having a score of at least 15 in the subgroup of negative marks on the PANSS assessment scale

排除标准

  • Other disorders in axis 1
  • The presence of cardiac disorders, liver disorders, kidney disorders and etc.
  • History of allergy to second-generation antipsychotics
  • Positive test for amphetamines or methamphetamines at initiate time of admission
  • Pregnancy or breastfeeding
  • Simultaneous treatment with anticholinergic drugs
  • The existence of suicidal thoughts

研究者

相似试验

Evaluation the Effect of Adding Galantamine to... | 临床试验